Latest News
Feature
Hypoxia-related discoveries net Nobel Prize
A trio of physician scientists have won the Nobel Prize for their work, which has implications for the treatment of anemia, cancer, and other...
Conference Coverage
Romosozumab benefits prevail, despite renal insufficiency
ORLANDO – Romosozumab (Evenity) did not noticeably affect increases in BMD or lowered vertebral fracture incidence among patients with various...
News from the FDA/CDC
Twin births down among women 30 and older
Race and ethnicity also played a role in the decline in twin birthrates since 2014.
Conference Coverage
AAFP Congress adopts resolutions on physician privileges, medical education, employee benefits
PHILADELPHIA – The Reference Committee on Education recommended a few of their heavily debated resolutions be referred to the AAFP board.
Conference Coverage
Consider cognitive reframing of osteoporosis to improve adherence
ORLANDO – Counter negative patient perceptions about osteoporosis treatment by explaining the risks of treatment with medications as well as the...
From the Journals
Supine sleep in late pregnancy may promote low birth weight
But the number of supine sleepers was low in this study, and reasons for sleeping supine were not determined.
Conference Coverage
Osteoporosis remains a costly burden to older U.S. adults
ORLANDO – Older women and minorities continue to bear the brunt of the burden of fragility fractures in the United States.
From the Journals
High maternal lead levels linked to children’s obesity
High maternal folate levels mitigated the association between children’s risk of obesity and mothers’ high lead levels, suggesting an...
Feature
Medical boards change or consider amending mental health-related licensing questions
Florida’s current medical licensing application may deter physicians from seeking care if they develop conditions such as depression, says Delicia...
Latest News
Gene recurrence score helps predict successful combination therapy for early breast cancer
Women with a high recurrence score on a 21-gene breast cancer assay fared better with chemoendocrine therapy than expected with endocrine therapy...
Conference Coverage
PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer
BARCELONA – Benefit was particularly pronounced in patients with a tumor BRCA mutation and those with homologous recombination deficiency (HRD)–...